(Reuters) – Healthcare conglomerate Johnson & Johnson said it would cut about 3,000 jobs within its medical devices division, or between 4 percent and 6 percent of the unit’s global workforce, over the next two years. Leerink analysts said the announcement meant that an acquisition was still on the cards for J&J, given that it had about $37 billion in cash as of the end of the third quarter. “We continue to believe JNJ is an active acquirer with a focus likely heavily weighted toward it’s lagging Medical Devices business…it’s a matter of when, not if, JNJ does a deal”, they wrote in a note.